Xstrahl Medical joined the best in UK radiation oncology at the second annual UKRCO congress, focusing on new technologies and techniques to enhance patient experiences, and clinical efficiencies. “UKRCO 2017 in Manchester represented cohesion in diagnostic imaging...
June 7th, 2017 – Recent surveys show that over half of the British population are unaware that radiotherapy options exist for cancers, benign conditions or palliative care1. This means that thousands of patients could be missing out on the best possible treatment....
Xstrahl is looking forward to participating in ARR 2017: Improving Radiotherapy Response through Radiation Research conference, which will take place on 26 - 28 June at St Hilda's College, Oxford. The three day annual event is aimed to trigger discussion on the latest...
Xstrahl is pleased to be invited as a sponsor for BACR Tumour Microenvironment: Basic Science to Novel Therapies conference and BACR 3D Models Workshop taking place on 14 - 16 June in Nottingham, UK. The conference will cover a wide number of topics with sessions on...
ESTRO 36 in Vienna, Austria saw Xstrahl Medical and Life Sciences come together to display some of the advances in radiotherapy solutions over the last year between the 5th and 9th of May 2017.
The SARRP User Spring Symposium event gathers together thought leaders, scholars and operators of Xstrahl Small Animal Radiation Research (SARRP) systems from all over the world.
April 5th, 2017 – Xstrahl is pleased to announce the supply of the first superficial radiotherapy system – Xstrahl 200 to Havana, Cuba. The equipment was installed in early 2016 and has now been successfully treating Cuban cancer patients for the last 12 months....
The Annual Meeting of the American Society for Radiation Oncology (ASTRO) conference in Boston, September 26 – 28, will see Xstrahl Ltd (Booth 7057) showcase a range of new and updated products and systems. The Medical side of the business will be presenting the updated Photoelectric Therapy system, whilst Xstrahl Life Sciences highlights the recent developments and new accessories for SARRP. The ASTRO Annual Meeting is the world’s most important meeting for the radiation oncology community, with more than 11,000 people attending.
NICE (National Institute for Health and Care Excellence) has announced a new Medtech Innovation Briefing (MIB)1 stating that NHS doctors and commissioners may consider Single Dose Intraoperative Radiotherapy (SD-IORT) using Xstrahl distributed Xoft Axxent eBx as a treatment option for early stage breast cancer patients. A single dose of intraoperative radiotherapy (IORT) is an effective and convenient alternative to daily conventional radiotherapy for appropriate early stage breast cancer patients.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
